Evidence map›Paper›PMID 32277490›Full record

ArticlePrenatal diagnosis2020

SARS-CoV2 (COVID-19) infection: is fetal surgery in times of national disasters reasonable?

Jan Deprest, Marc Van Ranst, Lore Lannoo, Emma Bredaki, Greg Ryan, Anna David, Jute Richter, Tim Van Mieghem

Abstract readLetter
In one paragraph

Article in Prenatal diagnosis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Invasive prenatal diagnosis during COVID-19 pandemic.Archives of gynecology and obstetrics · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Fetal Surgery in the Era of SARS-CoV-2 Pandemic: A Single-Institution Review.Mayo Clinic proceedings. Innovations, quality & outcomes · 2020
    Article
  7. Adaptation of prenatal care and ultrasound.Seminars in perinatology · 2020
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jan DeprestDepartment of Obstetrics and Gynaecology, Fetal Medicine Unit, UZ Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0002-4920-945X
Marc Van RanstLaboratory Medicine, UZ Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0002-1674-4157
Lore LannooDepartment of Obstetrics and Gynaecology, Fetal Medicine Unit, UZ Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0002-6271-221X
Emma BredakiDepartment of Obstetrics and Gynaecology, Fetal Medicine Unit, University College London Hospital, London, UK.ORCID https://orcid.org/0000-0002-3583-8757
Greg RyanDepartment of Obstetrics and Gynaecology, Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-5456-7622
Anna DavidDepartment of Obstetrics and Gynaecology, Fetal Medicine Unit, University College London Hospital, London, UK.ORCID https://orcid.org/0000-0002-0199-6140
Jute RichterDepartment of Obstetrics and Gynaecology, Fetal Medicine Unit, UZ Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0001-8415-6747
Tim Van MieghemDepartment of Obstetrics and Gynaecology, Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0002-3034-6905

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Even though the global COVID-19 pandemic may affect how medical care is delivered in general, most countries try to maintain steady access for women to routine pregnancy care, including fetal anomaly screening. This means that, also during this pandemic, fetal anomalies will be detected, and that discussions regarding invasive genetic testing and possibly fetal therapy will need to take place. For patients, concerns about Severe Acute Respiratory Syndrome-Corona Virus 2 will add to the anxiety caused by the diagnosis of a serious fetal anomaly. Yet, also for fetal medicine teams the situation gets more complex as they must weigh up the risks and benefits to the fetus as well as the mother, while managing a changing evidence base and logistic challenges in their healthcare system.

Indexed as

COVID-19Fetal TherapiesPandemicsDisastersFemaleHumansInfectious Disease Transmission, VerticalPregnancyPregnancy Complications, Infectious

Identifiers

PMID32277490
PMCPMC7262344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.